Q2 2025 · 13F-HR
STEMPOINT CAPITAL LPholdings as filed
Filed 2025-08-14 · accession 0001420506-25-002033
$311.6M
Reported value
53
Positions
2025-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $22.2M | 7.13% | 2,372,634 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $20.8M | 6.68% | 1,300,860 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $18.7M | 6.00% | 528,115 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $16.6M | 5.34% | 1,265,672 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $15.9M | 5.12% | 52,694 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $14.0M | 4.49% | 266,094 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $13.3M | 4.26% | 201,452 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $13.0M | 4.17% | 266,774 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $11.2M | 3.58% | 176,752 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $10.0M | 3.22% | 351,124 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $9.9M | 3.18% | 707,915 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $9.6M | 3.08% | 270,144 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $9.4M | 3.01% | 6,649,244 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $8.8M | 2.81% | 250,438 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $8.6M | 2.74% | 631,586 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $8.0M | 2.56% | 572,615 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $6.8M | 2.18% | 601,781 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $6.2M | 2.00% | 116,779 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $6.2M | 1.99% | 61,578 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $6.1M | 1.97% | 686,539 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $5.9M | 1.88% | 900,338 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $5.4M | 1.73% | 183,912 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $4.6M | 1.47% | 59,828 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $4.4M | 1.40% | 386,790 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $4.1M | 1.32% | 2,413,254 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $3.7M | 1.18% | 84,466 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $3.5M | 1.12% | 165,885 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $3.5M | 1.11% | 1,143,677 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $3.3M | 1.06% | 315,812 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $3.1M | 0.99% | 329,254 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $2.9M | 0.93% | 205,672 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $2.9M | 0.92% | 644,654 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $2.8M | 0.89% | 1,203,941 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $2.8M | 0.89% | 152,652 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $2.5M | 0.79% | 174,754 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $2.5M | 0.79% | 4,672 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $2.4M | 0.76% | 54,630 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $2.1M | 0.67% | 89,933 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $2.0M | 0.65% | 200,785 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $1.6M | 0.52% | 141,021 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $1.6M | 0.51% | 150,000 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $1.4M | 0.44% | 32,255 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $1.2M | 0.39% | 100,826 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $1.1M | 0.34% | 208,800 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $926,761 | 0.30% | 16,770 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $794,800 | 0.26% | 40,000 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $759,206 | 0.24% | 283,286 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $700,554 | 0.22% | 7,407 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $671,272 | 0.22% | 87,748 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $617,625 | 0.20% | 915,000 | CALL | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $589,629 | 0.19% | 90,852 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $310,000 | 0.10% | 100,000 | CALL | SOLE |
| 374163103 | GERN | GERON CORP | $52,500 | 0.02% | 300,000 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.